Literature DB >> 9451509

Isolation of the [3H]gabapentin-binding protein/alpha 2 delta Ca2+ channel subunit from porcine brain: development of a radioligand binding assay for alpha 2 delta subunits using [3H]leucine.

J P Brown1, V U Dissanayake, A R Briggs, M R Milic, N S Gee.   

Abstract

The novel antiepileptic agent gabapentin (Neurontin) binds with high affinity to the alpha 2 delta subunit of a voltage-dependent Ca2+ channel. We report here a simple purification scheme for detergent-solubilized alpha 2 delta subunits from porcine brain. This involves sequential chromatography on Q-Sepharose, Cu(2+)-charged iminodiacetic acid-Sepharose, wheat germ lectin-agarose, and Mono Q. The purified protein was essentially homogeneous by SDS-polyacrylamide gel electrophoresis with a subunit Mr of 145,000. Using [3H] gabapentin as the radiolabeled tracer and (S)-3-isobutyl gamma-aminobutyric acid to define nonspecific binding, the overall purification factor was 2760-fold and the apparent yield 26.6%. We also developed and validated a novel binding assay for alpha 2 delta Ca2+ channel subunits using the ligand pair L-[3H]leucine/L-isoleucine. Even in binding assays of crude brain membrane fractions, [3H]leucine proved to be remarkably stable and specific for the alpha 2 delta Ca2+ channel subunit. [3H]Leucine offers several advantages over custom-labeled [3H]gabapentin: it has a higher specific activity, is relatively inexpensive, and is available from commercial sources.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9451509     DOI: 10.1006/abio.1997.2447

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  22 in total

Review 1.  Calcium channel alpha2delta subunits: differential expression, function, and drug binding.

Authors:  Norbert Klugbauer; Else Marais; Franz Hofmann
Journal:  J Bioenerg Biomembr       Date:  2003-12       Impact factor: 2.945

Review 2.  Prophylactic migraine therapy: mechanisms and evidence.

Authors:  Nabih M Ramadan
Journal:  Curr Pain Headache Rep       Date:  2004-04

3.  The alpha2delta ligand gabapentin inhibits the Rab11-dependent recycling of the calcium channel subunit alpha2delta-2.

Authors:  Alexandra Tran-Van-Minh; Annette C Dolphin
Journal:  J Neurosci       Date:  2010-09-22       Impact factor: 6.167

Review 4.  Pregabalin in the treatment of chronic pain: an overview.

Authors:  S Chiechio; M Zammataro; F Caraci; L Rampello; A Copani; A F Sabato; F Nicoletti
Journal:  Clin Drug Investig       Date:  2009       Impact factor: 2.859

5.  Molecular diversity of the calcium channel alpha2delta subunit.

Authors:  N Klugbauer; L Lacinová; E Marais; M Hobom; F Hofmann
Journal:  J Neurosci       Date:  1999-01-15       Impact factor: 6.167

Review 6.  Calcium channel auxiliary α2δ and β subunits: trafficking and one step beyond.

Authors:  Annette C Dolphin
Journal:  Nat Rev Neurosci       Date:  2012-07-18       Impact factor: 34.870

7.  Isolation and characterization of the 5´-upstream region of the human voltage-gated Ca(2+) channel α 2δ-1 auxiliary subunit gene: promoter analysis and regulation by transcription factor Sp1.

Authors:  Elizabeth Martínez-Hernández; Ricardo González-Ramírez; Alejandro Sandoval; Bulmaro Cisneros; Rodolfo Delgado-Lezama; Ricardo Felix
Journal:  Pflugers Arch       Date:  2012-12-15       Impact factor: 3.657

8.  Pharmacological disruption of calcium channel trafficking by the alpha2delta ligand gabapentin.

Authors:  Jan Hendrich; Alexandra Tran Van Minh; Fay Heblich; Manuela Nieto-Rostro; Katrin Watschinger; Jörg Striessnig; Jack Wratten; Anthony Davies; Annette C Dolphin
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-25       Impact factor: 11.205

9.  Smooth muscle cell alpha2delta-1 subunits are essential for vasoregulation by CaV1.2 channels.

Authors:  John P Bannister; Adebowale Adebiyi; Guiling Zhao; Damodaran Narayanan; Candice M Thomas; Jessie Y Feng; Jonathan H Jaggar
Journal:  Circ Res       Date:  2009-10-01       Impact factor: 17.367

Review 10.  The Physiology, Pathology, and Pharmacology of Voltage-Gated Calcium Channels and Their Future Therapeutic Potential.

Authors:  Gerald W Zamponi; Joerg Striessnig; Alexandra Koschak; Annette C Dolphin
Journal:  Pharmacol Rev       Date:  2015-10       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.